2O' REILLY R A, TRAGER W F, RETTIE A E, et al. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans [ J ]. Clin Pharmacol Ther, 1997,42 ( 3 ) : 290-294.
3WATT A H, STEPHENS M R, BUSS D C, et al. Amiodarone reduces plasma warfarin clearance in man [ J]. Br J Clin Pharmacol, 1985,20(6) :707-709.
4CHEUNG B, LAM F M, KUMANA C R. Insidiously evolving, occult drug interaction involving warfarin and amiodarone [ J ]. BMJ, 1996, 312 (7023) : 107-108.
5SANOSKI C A, BAUMAN J L. Clinical observations with the amiodarone/warfarin interaction[ J]. Chest, 2002,121 ( 1 ) : 19- 23.
6HIRSH J, FUSTER V, ANSELL J, et al. American heart association / amerian college of cardiology foundation guide to warfarin therapy [ J ]. Circulation, 2003,107 ( 102 ) : 1692-1711.
7MIAO L, YANG J, HUANG C, et al. Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients [ J ]. Eur J Clin Pharmacol, 2007,63 ( 12 ) : 1135- 1141.
8RIEDER M J, REINER A P, GAGE B F, et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose [ J ]. N Engl J Med, 2005,352 (22) :2285-2293.
9WADELIUS M, CHEN L Y, LINDH J D, et al. The largest prospective warfarin-treated cohort supports genetic forecasting[J]. Blood, 2009,113 (4) :784-792.
10KERIN N Z, BLEVINS R D, GOLDMAN L, et al. The incidence, magnitude, and time course of the amiodarone-warfarin interaction [ J ]. Arch Intern Med, 1988, 148 (8) : 1779-1781.
